Salk researchers uncover molecular mechanisms of HIV drug resistance

FHS
July 22, 2023
1:13 am

Salk Institute researchers, in collaboration with the National Institutes of Health, have discovered the molecular mechanisms by which the human immunodeficiency virus (HIV) becomes resistant to Dolutegravir, one of the most effective, clinically used antiviral drugs for treating HIV.

Business for Sale – Indiva Limited

Business for Sale PricewaterhouseCoopers Inc., LIT, in its capacity as the court-appointed monitor (the “Monitor”) of: Indiva Limited, Indiva Amalco Ltd., Indiva Inc., Vieva Canada

July 10, 2024

Once again, Novo’s semaglutide shows cardiovascular benefit, weight loss — this time in adults with heart failure

Novo Nordisk’s GLP-1 Wegovy has shown cardiovascular benefit again, this time in the Phase III STEP HFpEF trial, on top of the expected weight loss,

August 26, 2023

Dewpoint Therapeutics restructures to ‘make room’ for entry into the clinic next year in oncology, ALS

Condensate modulator startup Dewpoint Therapeutics is going through a restructuring as it gears up for its first clinical trials next year in colorectal cancer and

January 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.